KV Pharmaceutical
This article was originally published in The Tan Sheet
Executive Summary
Former Boehringer Mannheim President Ted Wood joins as president and CEO of St. Louis-based KV. Wood succeeds Mark Hermelin as CEO, while Hermelin retains his vice chair post. Wood previously spent 15 years at Beecham Labs and served as its president when it merged with SmithKline in 1989. While at Beecham, sales grew from $24 mil. to over $500 mil. Wood had been president at Boehringer Mannheim since January 1992